CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 48 filers reported holding CONMED CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,486,736 | +7.3% | 2,016,000 | -1.0% | 0.01% | +9.1% |
| Q4 2022 | $2,318,106 | -4.7% | 2,037,000 | -7.8% | 0.01% | 0.0% |
| Q3 2022 | $2,432,000 | -13.9% | 2,209,000 | -5.1% | 0.01% | -8.3% |
| Q2 2022 | $2,824,000 | -92.7% | 2,328,000 | -89.7% | 0.01% | -91.8% |
| Q1 2022 | $38,817,000 | +1.4% | 22,651,000 | -1.4% | 0.15% | +2.1% |
| Q4 2021 | $38,271,000 | +7.0% | 22,961,000 | -0.4% | 0.14% | -8.3% |
| Q3 2021 | $35,765,000 | -4.2% | 23,047,000 | -0.2% | 0.16% | -8.8% |
| Q2 2021 | $37,345,000 | +3.7% | 23,085,000 | +0.5% | 0.17% | -12.8% |
| Q1 2021 | $36,014,000 | +11.6% | 22,981,000 | -0.1% | 0.20% | +4.8% |
| Q4 2020 | $32,262,000 | +26.0% | 23,007,000 | +1.1% | 0.19% | +13.3% |
| Q3 2020 | $25,610,000 | +13.1% | 22,766,000 | +5.7% | 0.16% | +3.1% |
| Q2 2020 | $22,653,000 | +19.5% | 21,531,000 | +6.2% | 0.16% | +7.4% |
| Q1 2020 | $18,959,000 | – | 20,269,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,115,000 | $4,708,428 | 0.71% |
| ZAZOVE ASSOCIATES LLC | 5,455,000 | $6,306 | 0.58% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,076,000 | $4,644,575 | 0.29% |
| MACKAY SHIELDS LLC | 6,287,000 | $7,123,996 | 0.18% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 15,994,000 | $18,201,172 | 0.13% |
| WOLVERINE ASSET MANAGEMENT LLC | 8,997,000 | $10,397,505 | 0.11% |
| Teton Advisors, Inc. | 350,000 | $404,604 | 0.10% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,264,000 | $3,759,802 | 0.10% |
| Calamos Wealth Management LLC | 384,000 | $436,992 | 0.03% |
| GABELLI FUNDS LLC | 3,000,000 | $3,468,030 | 0.03% |